Trying to improve clinical outcome in AML: Lessons from negative trials
To access this article, please choose from the options below
PII: S0145-2126(05)00048-2
doi:10.1016/j.leukres.2004.12.013
© 2005 Elsevier Ltd. All rights reserved.
PII: S0145-2126(05)00048-2
doi:10.1016/j.leukres.2004.12.013
© 2005 Elsevier Ltd. All rights reserved.